is an intracellular, fastidious, Gram-negative bacterium that is difficult to identify using routine microbiological methods in the laboratory. We studied the isolation of sp. (strain IDAMR664) from the blood of a patient with anti-interferon-γ (IFN-γ) autoantibodies who presented with septicemia and cholestatic hepatitis. Analysis of the strain IDAMR664 genome sequence revealed the isolate was closely related to the strain GA01-2794 that had been isolated from a human in the USA. In addition, it was clustered with , a fish pathogen. The isolate contained several virulence factors and had pathogenicity island pattern no. 3.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874608 | PMC |
| http://dx.doi.org/10.3390/tropicalmed7020025 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
PDZK1 gene transfer ameliorates lipopolysaccharide-induced cholestasis in rats by rescuing hepatic ABC transporters.
Biosci Biotechnol Biochem
December 2024
Central Laboratory, Department of Pharmacy, Wuhan Fourth Hospital, Wuhan, China.
Lipopolysaccharide (LPS) causes inflammatory cholestasis in sepsis. We investigated the role of PDZK1 in the repression of ABC transporters in LPS-induced cholestasis. Lentiviral gene transfer of PDZK1 to rats was conducted to explore its influence on cholestasis induced by LPS.
View Article and Find Full Text PDFDrug-induced cholestatic liver diseases.
Hepatology
August 2024
Department of Gastroenterology and Hepatology, St. John's Medical College Hospital, Bangalore, India.
Cholestatic DILI is an important and frequently challenging differential diagnosis in patients presenting with elevated liver tests with predominant elevation in alkaline phosphatase. A number of competing etiologies need to be ruled out, such as hepatobiliary malignancy, choledocholithiasis, cholestatic forms of viral hepatitis, cholestasis of sepsis, primary and secondary cholangitis, and right-sided cardiac failure to name a few. Important advances have occurred in the understanding and knowledge of the clinical phenotypes, new etiological agents, risk factors, pathophysiology, and genetic determinants of drug-induced cholestasis since the last review on drug-induced cholestasis was published in Hepatology in 2011.
View Article and Find Full Text PDFApplication of Nanoparticles as Novel Adsorbents in Blood Purification Strategies.
Blood Purif
September 2024
Department of Nephrology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Background: Blood purification therapy for patients overloaded with metabolic toxins or drugs still needs improvement. Blood purification therapies, such as in hemodialysis or peritoneal dialysis can profit from a combined application with nanoparticles.
Summary: In this review, the published literature is analyzed with respect to nanomaterials that have been customized and functionalized as nano-adsorbents during blood purification therapy.
Hepatitis C viremic lung transplantation to aviremic recipients: Comprehensive outcomes and post-transplant viremia.
Clin Transplant
May 2024
Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, Ohio, USA.
Article Synopsis
- Direct-acting antiviral (DAA) therapy allows safe lung transplants from HCV-viremic donors (D+) to aviremic recipients (D-), but midterm outcomes were previously unclear.
- A study of 500 lung transplant patients (2018-2022) found no significant differences in patient and graft survival between D+ and D- groups at 1 and 2 years post-transplant.
- The research concluded that using HCV-viremic organs in selected patients is safe and does not lead to additional complications or different rejection rates compared to aviremic organs.
Mitochondrial Diabetes Mellitus With Mitochondrial DNA 3316G>A Mutation: A Unique Autopsy Case Presenting With Sepsis-Associated Cholestasis.
Cureus
April 2024
Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada, JPN.
A 70-year-old female, diagnosed with mitochondrial diabetes mellitus (MDM) showing previously a point mutation at mitochondrial DNA 3316G>A, noticed urinary tract infection and diabetic gangrene of the foot with Gram-negative bacteremia, followed by aggressive jaundice with high serum level of direct bilirubin. She died two months after the symptom onset. At autopsy, multiple foci of bacteremia-induced hemorrhagic infarction were observed in the congestive bilateral lungs, whereas the cholestatic liver revealed no overt gross cholangiectasis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!